The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.

@article{Bartalena2016The2E,
  title={The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.},
  author={Luigi Bartalena and Lelio Baldeschi and Kostas Boboridis and A. Eckstein and G J Kahaly and Claudio Marcocci and P Perros and Mario Salvi and Wilmar Maarten Wiersinga},
  journal={European thyroid journal},
  year={2016},
  volume={5 1},
  pages={9-26}
}
Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease, though severe forms are rare. Management of GO is often suboptimal, largely because available treatments do not target pathogenic mechanisms of the disease. Treatment should rely on a thorough assessment of the activity and severity of GO and its impact on the patient's quality of life. Local measures (artificial tears, ointments and dark glasses) and control of risk factors for progression (smoking and… CONTINUE READING
Highly Influential
This paper has highly influenced 13 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 49 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 142 references

Management of patients with Graves ’ orbitopathy : initial assessment , management outside specilised centres and referral pathways

  • Z Onaran, O Konuk, SO Oktar, C Yucel, M Unal
  • Clin Med
  • 2015

Ocular surface drying

  • JP Gilbard, RL Farris
  • syndrome. Clin Ophthalmol 2015;
  • 2015

Similar Papers

Loading similar papers…